Cargando…

Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study

BACKGROUND: More than 70% of patients continue to use opioid medications 3-weeks following total knee arthroplasty. Post-discharge pharmacist reviews improve medication management, however it’s effect on opioid usage is not known. AIM: This study aimed to evaluate the impact of post-discharge pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Tim, Ford, James, Hardidge, Andrew, Antoine, Shari, Veevers, Beth, Taylor, Simone, Elliott, Rohan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277971/
https://www.ncbi.nlm.nih.gov/pubmed/35829822
http://dx.doi.org/10.1007/s11096-022-01455-y
_version_ 1784746099323437056
author Tran, Tim
Ford, James
Hardidge, Andrew
Antoine, Shari
Veevers, Beth
Taylor, Simone
Elliott, Rohan A.
author_facet Tran, Tim
Ford, James
Hardidge, Andrew
Antoine, Shari
Veevers, Beth
Taylor, Simone
Elliott, Rohan A.
author_sort Tran, Tim
collection PubMed
description BACKGROUND: More than 70% of patients continue to use opioid medications 3-weeks following total knee arthroplasty. Post-discharge pharmacist reviews improve medication management, however it’s effect on opioid usage is not known. AIM: This study aimed to evaluate the impact of post-discharge pharmacist review on opioid use following a total knee arthroplasty. METHOD: A pilot, cohort pre- and post-intervention study was undertaken on patients who had undergone a total knee arthroplasty and were supplied an opioid upon discharge from hospital. During the intervention, patients were contacted via telephone by a pharmacist approximately five days post-discharge to review analgesic usage, provide education and advice and communicate an opioid management plan to their general practitioner. The primary endpoint was the percentage of patients taking opioids 3-weeks post-discharge. Secondary endpoints included: percentage of patients obtaining an opioid refill; patient satisfaction with opioid supply and the pharmacist review. RESULTS: Pre- and post-intervention, 63 and 44 patients were included, respectively. The percentage of patients taking opioids 3-weeks post-discharge declined from 74.6 to 29.6% (p < 0.001) and the percentage requiring an opioid refill from their general practitioner declined from 71.4 to 36.4% (p  < 0.001). More patients were satisfied with opioid supply during the intervention period (79.5% cf. 47.6%, p = 0.001). Twenty-eight (63.6%) patients could recall the post-discharge pharmacist review, and all were either satisfied or extremely satisfied with the review. CONCLUSION: Pharmacist-delivered post-discharge analgesia review reduced the percentage of patients taking opioids 3-weeks post-discharge following a total knee arthroplasty. This intervention has the potential to provide a smoother transition of care for patients supplied with opioids at the time of hospital discharge.
format Online
Article
Text
id pubmed-9277971
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-92779712022-07-14 Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study Tran, Tim Ford, James Hardidge, Andrew Antoine, Shari Veevers, Beth Taylor, Simone Elliott, Rohan A. Int J Clin Pharm Research Article BACKGROUND: More than 70% of patients continue to use opioid medications 3-weeks following total knee arthroplasty. Post-discharge pharmacist reviews improve medication management, however it’s effect on opioid usage is not known. AIM: This study aimed to evaluate the impact of post-discharge pharmacist review on opioid use following a total knee arthroplasty. METHOD: A pilot, cohort pre- and post-intervention study was undertaken on patients who had undergone a total knee arthroplasty and were supplied an opioid upon discharge from hospital. During the intervention, patients were contacted via telephone by a pharmacist approximately five days post-discharge to review analgesic usage, provide education and advice and communicate an opioid management plan to their general practitioner. The primary endpoint was the percentage of patients taking opioids 3-weeks post-discharge. Secondary endpoints included: percentage of patients obtaining an opioid refill; patient satisfaction with opioid supply and the pharmacist review. RESULTS: Pre- and post-intervention, 63 and 44 patients were included, respectively. The percentage of patients taking opioids 3-weeks post-discharge declined from 74.6 to 29.6% (p < 0.001) and the percentage requiring an opioid refill from their general practitioner declined from 71.4 to 36.4% (p  < 0.001). More patients were satisfied with opioid supply during the intervention period (79.5% cf. 47.6%, p = 0.001). Twenty-eight (63.6%) patients could recall the post-discharge pharmacist review, and all were either satisfied or extremely satisfied with the review. CONCLUSION: Pharmacist-delivered post-discharge analgesia review reduced the percentage of patients taking opioids 3-weeks post-discharge following a total knee arthroplasty. This intervention has the potential to provide a smoother transition of care for patients supplied with opioids at the time of hospital discharge. Springer International Publishing 2022-07-12 2022 /pmc/articles/PMC9277971/ /pubmed/35829822 http://dx.doi.org/10.1007/s11096-022-01455-y Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Article
Tran, Tim
Ford, James
Hardidge, Andrew
Antoine, Shari
Veevers, Beth
Taylor, Simone
Elliott, Rohan A.
Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study
title Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study
title_full Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study
title_fullStr Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study
title_full_unstemmed Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study
title_short Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study
title_sort evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277971/
https://www.ncbi.nlm.nih.gov/pubmed/35829822
http://dx.doi.org/10.1007/s11096-022-01455-y
work_keys_str_mv AT trantim evaluationofapostdischargepharmacistopioidreviewfollowingtotalkneearthroplastyapreandpostinterventioncohortstudy
AT fordjames evaluationofapostdischargepharmacistopioidreviewfollowingtotalkneearthroplastyapreandpostinterventioncohortstudy
AT hardidgeandrew evaluationofapostdischargepharmacistopioidreviewfollowingtotalkneearthroplastyapreandpostinterventioncohortstudy
AT antoineshari evaluationofapostdischargepharmacistopioidreviewfollowingtotalkneearthroplastyapreandpostinterventioncohortstudy
AT veeversbeth evaluationofapostdischargepharmacistopioidreviewfollowingtotalkneearthroplastyapreandpostinterventioncohortstudy
AT taylorsimone evaluationofapostdischargepharmacistopioidreviewfollowingtotalkneearthroplastyapreandpostinterventioncohortstudy
AT elliottrohana evaluationofapostdischargepharmacistopioidreviewfollowingtotalkneearthroplastyapreandpostinterventioncohortstudy